Consistent with our expectations, ex vivo experiments on atherosclerosis have demonstrated that NOB can interfere with the atherosclerotic process by modulating core targets, such as ALB, AKT1, and CASP3. This evidence concerns the gene CASP3 and atherosclerosis.